Equities

Modern Healthcare Technology Holdings Ltd

Modern Healthcare Technology Holdings Ltd

Actions
  • Price (EUR)0.0115
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-14.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in HKDIncome statement in HKDView more

Year on year Modern Healthcare Technology Holdings Ltd grew revenues 11.91% from 406.33m to 454.71m while net income improved from a loss of 20.61m to a smaller loss of 9.57m.
Gross margin96.82%
Net profit margin-1.90%
Operating margin-0.44%
Return on assets-1.47%
Return on equity-4.92%
Return on investment-3.75%
More ▼

Cash flow in HKDView more

In 2024, Modern Healthcare Technology Holdings Ltd increased its cash reserves by 9.35%, or 16.07m. The company earned 78.66m from its operations for a Cash Flow Margin of 17.30%. In addition the company generated 8.17m cash from investing, though they paid out 70.60m more in financing than they received.
Cash flow per share0.0752
Price/Cash flow per share1.20
Book value per share0.2093
Tangible book value per share0.2093
More ▼

Balance sheet in HKDView more

Modern Healthcare Technology Holdings Ltd has a Debt to Total Capital ratio of 35.41%, a higher figure than the previous year's 7.18%.
Current ratio1.01
Quick ratio0.9827
Total debt/total equity0.5629
Total debt/total capital0.3541
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.